Atea Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Atea Pharmaceuticals Inc
TickerAVIR
CIK #0001593899
CUSIP053761102
SectorLife Sciences - Pharmaceutical Preparations
Address125 Summer Street 16th Floor, Boston, MA 02110
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Atea Pharmaceuticals Inc 2020-05-29 107.5 M Exemption: 506(b) · Remaining: $107,499,667 · Duration: One year or less · Commission: $500,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001593899] 10-K
[0001593899] 10-Q
[0001593899] 3
[0001593899] 4
[0001593899] 8-K
[0001593899] D
[0001593899] SC 13D
[0001593899] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BML Investment Partners LP Atea Pharmaceuticals Inc [2026-02-09] 0.0
Radoff Bradley Louis Atea Pharmaceuticals Inc [2025-03-04] 0.0
BML Investment Partners LP Atea Pharmaceuticals Inc [2024-12-16] 0.0
BML Investment Partners LP Atea Pharmaceuticals Inc [2024-02-07] 6.5
BML Investment Partners LP Atea Pharmaceuticals Inc [2023-10-02] 5.0
Tang Capital Partners LP Atea Pharmaceuticals Inc [2023-05-22] 11.0
Vanguard Group Inc Atea Pharmaceuticals Inc [2022-02-09] 6.96
BlackRock Inc Atea Pharmaceuticals Inc [2022-02-04] 7.0
EcoR1 Capital LLC Atea Pharmaceuticals Inc [2021-12-10] 6.5
RA Capital Management LP Atea Pharmaceuticals Inc [2021-02-16] 6.5
Morningside Venture Investments Ltd Atea Pharmaceuticals Inc [2021-02-16] 8.03
Sommadossi Jean-Pierre Atea Pharmaceuticals Inc [2021-02-10] 7.2
FMR LLC Atea Pharmaceuticals Inc [2021-02-08] 0.0
Cormorant Asset Management LP Atea Pharmaceuticals Inc [2020-11-13] 3.02
Bain Capital Life Sciences Fund II LP Atea Pharmaceuticals Inc [2020-11-12] 5.8
Form 3/4/5 Filer 2011 - 2026
Kirsch Arthur S
Atea Pharmaceuticals Inc
Adams Jerome M
Berman Howard
Berger Franklin M
Lucidi Bruno
Duncan Barbara Gayle
Polsky Bruce
Murphy Polly A
Corcoran Andrea
Sommadossi Jean-Pierre
Horga Maria Arantxa
Vavricka John
Hammond Janet MJ
Foster Wayne
Cormorant Private Healthcare Fund I LP
Cormorant Asset Management LP
Cormorant Global Healthcare Master Fund LP
Chen Bihua
Cormorant Private Healthcare Fund II LP
Rock Springs Capital Master Fund LP
Rock Springs Capital Management LP
Rock Springs Capital LLC
Hack Andrew A F
Chu Chung K
Cheng Isaac
JPM Partners LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Corcoran Andrea
Stock Option (Right to Buy) · derivative
2026-03-11 Option exercise 60,000 $0.00
Corcoran Andrea
Common Stock
2026-03-11 Option exercise 60,000 $1.24 74,400
Sommadossi Jean-Pierre
Stock Option (Right to Buy) · derivative
2026-02-03 Option exercise 300,000 $0.00
Sommadossi Jean-Pierre
Common Stock
2026-02-03 Option exercise 300,000 $1.24 372,000
Horga Maria Arantxa
Common Stock
2026-01-31 Option exercise 51,283
Corcoran Andrea
Common Stock
2026-01-31 Option exercise 54,866
Corcoran Andrea
Common Stock
2026-01-31 Tax withheld 16,104 $4.24 68,281
Sommadossi Jean-Pierre
Common Stock
2026-01-31 Tax withheld 106,093 $4.24 449,834
Sommadossi Jean-Pierre
Common Stock
2026-01-31 Option exercise 272,983
Foster Wayne
Common Stock
2026-01-31 Tax withheld 12,132 $4.24 51,440
Foster Wayne
Common Stock
2026-01-31 Option exercise 41,333
Horga Maria Arantxa
Common Stock
2026-01-31 Tax withheld 16,073 $4.24 68,150
Hammond Janet MJ
Common Stock
2026-01-31 Tax withheld 14,136 $4.24 59,937
Horga Maria Arantxa
Restricted Stock Units · derivative
2026-01-31 Option exercise 9,750 $0.00
Horga Maria Arantxa
Stock Option (Right to Buy) · derivative
2026-01-31 Grant 173,500 $0.00
Vavricka John
Restricted Stock Units · derivative
2026-01-31 Option exercise 8,750 $0.00
Vavricka John
Stock Option (Right to Buy) · derivative
2026-01-31 Grant 119,520 $0.00
Vavricka John
Restricted Stock Units · derivative
2026-01-31 Option exercise 33,333 $0.00
Hammond Janet MJ
Restricted Stock Units · derivative
2026-01-31 Option exercise 11,250 $0.00
Hammond Janet MJ
Restricted Stock Units · derivative
2026-01-31 Option exercise 46,800 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 127 58,609,289
2025-12-31 111 55,917,800
2025-09-30 115 52,960,288
2025-06-30 107 51,703,986
2025-03-31 106 52,064,966
2024-12-31 109 55,447,606
2024-09-30 109 57,202,989
2024-06-30 106 56,105,409
2024-03-31 114 54,633,132
2023-12-31 109 54,742,423
2023-09-30 120 55,897,393
2023-06-30 134 56,001,079
Form 13F Holdings
Firm Period DFND Voting Shares
Curated Wealth Partners LLC [2026-06-30] OTR 0 144,282
Certified Advisory Corp [2026-06-30] SOLE 0 24,500
RFG Advisory LLC [2026-06-30] SOLE 0 14,875
Versant Capital Management Inc [2026-06-30] SOLE 4,220 4,220
Farther Finance Advisors LLC [2026-06-30] SOLE 0 245
True Wealth Design LLC [2026-06-30] SOLE 0 122
Gamma Investing LLC [2026-06-30] DFND 91 91
IFP Advisors LLC [2026-06-30] SOLE 73 73
FNY Investment Advisers LLC [2026-06-30] SOLE 5,000 4
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com